Net income of AbCellera Biologics under GAAP for the nine months of 2021 amounted to $93.516 million, up 48.8 times from $1.917 million in the previous year. Revenues increased 9.3 times to $235.872 million from $25.247 million a year earlier.
Net income of AbCellera Biologics under GAAP for the nine months of 2021 amounted to $93.516 million, up 48.8 times from $1.917 million in the previous year. Revenues increased 9.3 times to $235.872 million from $25.247 million a year earlier. 
investors.abcellera.com
English (US) 